Re:AstraZeneca may have provided incomplete efficacy data NIAID
by JamisonM on Tuesday March 23, 2021 @09:02AM
(#26554472)
Ah, OK. I wouldn't characterize the use of a preexisting regulatory channel that is present exactly for this purpose as "easing" but it is a perfectly fair position to take. Thanks!
It's my understanding that the EU has a similar concept.
(It's an entirely appropriate use of these regulatory concepts, of course; this sort of pandemic is precisely why they exist.)